Your browser doesn't support javascript.
loading
Stabilization of Cyclin-Dependent Kinase 4 by Methionyl-tRNA Synthetase in p16INK4a-Negative Cancer.
Kwon, Nam Hoon; Lee, Jin Young; Ryu, Ye-Lim; Kim, Chanhee; Kong, Jiwon; Oh, Seongeun; Kang, Beom Sik; Ahn, Hye Won; Ahn, Sung Gwe; Jeong, Joon; Kim, Hoi Kyoung; Kim, Jong Hyun; Han, Dae Young; Park, Min Chul; Kim, Doyeun; Takase, Ryuichi; Masuda, Isao; Hou, Ya-Ming; Jang, Sung Ill; Chang, Yoon Soo; Lee, Dong Ki; Kim, Youngeun; Wang, Ming-Wei; Kim, Sunghoon.
Afiliação
  • Kwon NH; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Lee JY; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826, Korea.
  • Ryu YL; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Kim C; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Kong J; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Oh S; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Kang BS; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Ahn HW; School of Life Science and Biotechnology, Kyungpook National University, Daegu, 41566, Korea.
  • Ahn SG; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Jeong J; Breast Cancer Center, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Korea.
  • Kim HK; Breast Cancer Center, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Korea.
  • Kim JH; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Han DY; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Park MC; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Kim D; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Takase R; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Masuda I; Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.
  • Hou YM; Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.
  • Jang SI; Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.
  • Chang YS; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Korea.
  • Lee DK; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Korea.
  • Kim Y; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Korea.
  • Wang MW; Medicinal Bioconvergence Research Center, Seoul National University, Suwon, 16229, Korea.
  • Basappa; The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Kim S; Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Palace Road, Bangalore, 560 001, India.
ACS Pharmacol Transl Sci ; 1(1): 21-31, 2018 Sep 14.
Article em En | MEDLINE | ID: mdl-32219202

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos